-
5 Drug Companies Profiting From Generics
Monday, August 4, 2014 - 8:29am | 864Read More...Leading generic drug maker Teva Pharmaceutical (NYSE: TEVA) posted better than expected earnings last week and raised its full-year profit forecast. There was plenty for investors to be concerned about, though. Sales of its best-selling product, Copaxone, were down for the quarter, and activist...
-
Morgan Stanley Provides Color on Sagent Pharmaceuticals, Overweight
Tuesday, June 21, 2011 - 6:36am | 105Read More...Morgan Stanley provided color on Sagent Pharmaceuticals (NASDAQ: SGNT). In a research report published today, Sagent commented on the company's new drug levofloxacin. In the report, Morgan Stanley states, "Levofloxacin adds to pipeline momentum story. The approval of Sagent/Strides generic...
-
Jefferies' Updates 6/3
Friday, June 3, 2011 - 9:58am | 1674Read More...Jefferies initiated coverage of Cisco Systems (NASDAQ: CSCO) with a Hold rating. At the same time, Jefferies put its price target on the company's stock to $15.75. In a research report published today, Jefferies states, "We believe it's too early for investors to commit to the stock as we're still...
-
UPDATE: Jefferies Initiates Sagent Pharmaceuticals at Buy
Friday, June 3, 2011 - 7:57am | 100Read More...Jefferies is out with its report today on Sagent Pharmaceuticals (NASDAQ: SGNT), initiating SGNT at Buy. In a note to clients, Jefferies writes, "Sagent is one of a few standalone generic injectables companies, and given high barriers to entry and limited competition, has compelling scarcity value...
-
Jefferies Initiates Sagent Pharmaceuticals At Buy, $31 PT
Friday, June 3, 2011 - 6:53am | 25Read More...Jefferies & Company has initiated coverage on Sagent Pharmaceuticals (NASDAQ: SGNT) with a Buy rating and $31 price target.
-
Bank of America Initiates Sagent Pharmaceuticals At Neutral, $27 PO
Tuesday, May 31, 2011 - 6:55am | 26Read More...Bank of America has initiated coverage on Sagent Pharmaceuticals (NASDAQ: SGNT) with a Neutral rating and $27 price objective.
